Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Mangoceuticals (MGRX) Revenue (2023 - 2025)

Mangoceuticals' Revenue history spans 3 years, with the latest figure at $84246.0 for Q3 2025.

  • For Q3 2025, Revenue fell 36.83% year-over-year to $84246.0; the TTM value through Sep 2025 reached $466908.0, down 38.16%, while the annual FY2024 figure was $615873.0, 15.81% down from the prior year.
  • Revenue for Q3 2025 was $84246.0 at Mangoceuticals, down from $168109.0 in the prior quarter.
  • Across five years, Revenue topped out at $245160.0 in Q3 2023 and bottomed at $84246.0 in Q3 2025.
  • The 3-year median for Revenue is $141237.0 (2023), against an average of $155366.1.
  • The largest YoY upside for Revenue was 112.56% in 2024 against a maximum downside of 56.93% in 2024.
  • A 3-year view of Revenue shows it stood at $244374.0 in 2023, then plummeted by 56.93% to $105247.0 in 2024, then decreased by 19.95% to $84246.0 in 2025.
  • Per Business Quant, the three most recent readings for MGRX's Revenue are $84246.0 (Q3 2025), $168109.0 (Q2 2025), and $109306.0 (Q1 2025).